One prominent eect of IFNs is their cell growthinhibitory activity. The mechanism behind this inhibition of proliferation is still not fully understood. In this study, the eect of IFN-a treatment on cell cycle progression has been analysed in three lymphoid cell lines, Daudi, U-266 and H9. Examination of the growth-arrested cell populations shows that Daudi cells accumulate in a G0-like state, whereas U-266 cells arrest later in G1. H9 cells are completely resistant to IFN-a's cell growthinhibitory eects. The G0/G1-phase arrest is preceded by a rapid induction of the cyclin-dependent kinase inhibitors (CKIs), p21 and p15. In parallel, the activities of the G1 Cdks are signi®cantly reduced. In addition to p21/p15 induction, IFN-a regulates the expression of another CKI, p27, presumably by a post-transcriptional mechanism. In the G1 Cdk-complexes, there is ®rst an increased binding of p21 and p15 to their respective kinases. At longer exposure times, when Cdk-bound p15 and p21 decline, p27 starts to accumulate. Furthermore, we found that IFN-a not only suppresses the phosphorylation of pRb, but also alters the phosphorylation and expression of the other pocket proteins p130 and p107. These data suggest that induction of p21/p15 is involved in the primary IFN-a response inhibiting G1 Cdk activity, whereas increased p27 expression is part of a second set of events which keep these Cdks in their inactive form. Moreover, elevated levels of p27 correlated with a dissociation of cyclin E/Cdk2-p130 or p107 complexes to yield cyclin E/Cdk2-p27 complexes. In resistant H9 cells, which possess a homozygous deletion of the p15/p16 genes and lack p21 protein expression, IFN-a causes no detectable changes in p27 expression and, furthermore, no eects are observed on either pocket proteins in this cell line. Taken together, these data suggest that the early decline in G1 Cdk activity, subsequent changes in phosphorylation of pocket proteins, and G1/G0 arrest following IFN-a treatment, is not primarily due to loss of the G1 kinase components, but result from the inhibitory action of CKIs on these complexes.
Introduction
To ensure tissue homeostasis, the mitotic cycle has to be tightly controlled and yet remain exquisitely sensitive to changes in the environment. A large number of growth factors have been found to date. In contrast, only a small number of cytokines, which act as inhibitors of cell growth, have been described. The interferon (IFN) family of proteins is one wellknown example of such cell growth-inhibitory cytokines (Taylor-Papadimitriou and Rozengurt, 1985) .
In all organisms studied so far, temporal order and continued passage through the cell cycle is dependent on the sequential formation and activation of a series of serine/threonine protein kinases (Pines, 1995) . These kinases comprise of complexes consisting of a regulatory subunit, termed the cyclin, and a catalytic subunit called the cyclin dependent kinase (Cdk) (Pines, 1995) . Several dierent mechanisms are employed to regulate Cdk activity (Morgan, 1995) . First, monomeric Cdks have almost no kinase activity, and require binding of the cyclin partner in order to attain kinase activity. The cyclins typically undergo periodic accumulation and degradation during the cell cycle, but are also induced by exogenous growth factors . Second, activation of the Cdks requires, in addition to cyclin binding, phosphorylation of a conserved threonine residue by the cdkactivating kinase (CAK), as well as dephosphorylation at conserved threonine and tyrosine residues (Morgan, 1995) . Third, the kinases are subject to inhibition through binding of various cdk inhibitory proteins, termed cyclin-dependent kinase inhibitors (CKIs), hence providing an additional level of regulation to cell cycle control (Sherr and Roberts, 1995) .
Two families of mammalian CKIs have been identi®ed to date, termed INK4 and CIP/KIP (Sherr and Roberts, 1995) . The INK4 proteins are structurally distinct from the CIP/KIP proteins, and interact with the cyclins and Cdks in a dierent manner. The INK4 family members, including the p16 Ink4a , p15
Ink4b
, p18
Ink4c and p19
Ink4d proteins (Sherr and Roberts, 1995) , all contain tandem repeats of an ankyrin-like sequence, whereas the three members of the CIP/KIP family, p21 Cip1/Waf1 However, recent ®ndings suggest that the INK4 inhibitors may also stably interact with pre-formed complexes containing both cyclin D and Cdk4/6 (ReynisdottõÁ r and MassagueÂ , 1997) . The CIP/KIP proteins, on the other hand, bind to a wide range of cyclin/Cdk complexes, including the early G1 kinases cyclin D/Cdk4/6, the late G1 kinase cyclin E/Cdk2, as well as the cyclin A/Cdk2 kinase, which is active throughout S phase and G2. These inhibitors bind to cyclin/Cdk complexes with an anity which is higher than that of their binding to monomeric Cdks alone (Hall et al., 1995) , and their association appears both to block the activation of the Cdk by CAK, but may also inactivate pre-formed CAK phosphorylated complexes (Aprelikova et al., 1995) . Ectopic expression of CKIs induces G1 arrest, and numerous observations link CKIs to growth arrest in diverse cell types (Sherr and Roberts, 1995) Although the dierent CKI's show structural similarities within their respective families, the individual family members seem to have distinct cellular functions. For example, the p21 gene is mediating p53-induced cell cycle arrest (El-Deiry et al., 1993) , although p53-independent induction of p21 can also occur (Datto et al., 1995; GrandeÂ r et al., 1997) . The expression of p27 is high in cells inhibited by cell contact, serum deprivation and cAMP Polyak et al., 1994) . p27 has also been shown to be important in keeping cells in a quiescent state and declines upon mitogenic stimulation of resting cells (Nourse et al., 1994) . In the INK4 family, p15 expression is induced upon treatment with TGFb (Hannon and Beach, 1994) . In fact, several CKIs have been suggested as important mediators of antiproliferative cytokines. Both p15 from the INK4, and p21/p27 from the CIP/KIP family, have been shown to be involved in mediating negative regulation of cell proliferation in response to the antiproliferative cytokines TGF-b and IFN-a (ReynisdottõÁ r and MassagueÂ , 1997; GrandeÂ r et al., 1997) . In addition, Cdk inhibitors have been shown to be involved in dierentiation and replicative senescence (Kranenburg et al., 1995; Erickson et al., 1998) . Interestingly, of the dierent CKI's only the p16 and p15 genes are commonly lost in malignant cells, and at least p16 clearly seems to ful®ll the criteria of a tumor suppressor gene, whereas this does not seem to be the case for the other inhibitors (Palmero and Peters, 1996) .
Many proteins have been suggested as substrates for the dierent cyclin/Cdk complexes. Some of the most well-studied substrates include the retinoblastoma (pRb) family of proteins (Weinberg, 1995) . This family consists of pRb and the related proteins p107 and p130, collectively termed the pocket proteins. During G1 to S phase progression of the cell cycle, the activation of cyclin/Cdk complexes leads to phosphorylation of dierent members of the pocket protein family, release of E2F transcription factors, and activation of E2F-dependent transcription. Conversely, in their unphosphorylated active form, pocket proteins inhibit cell cycle progression, possibly through their physical association with dierent E2F family members (Weinberg, 1995; Vairo et al., 1995) .
Analysis of mouse strains carrying inactivated alleles of the murine homologs of Rb, p107 and p130, indicate the existence of both shared and unique functions of these proteins (Lee et al., 1996; Mulligan et al., 1998) . This is supported by the observation that each pocket protein can interact with distinct cellular proteins, and that each inhibits cell cycle progression only in distinct subsets of tumor cell lines (Vairo et al., 1995; Zhu et al., 1995a) . In addition to the pocket domain that interacts with the E2Fs, p107 and p130 possess a second region within the pocket, termed the`spacer', which is dedicated to binding cyclin E and A complexes. Indeed, p107 and p130 have been shown to form stable complexes with cyclin/Cdk2 kinases, as well as with E2F and its heterodimeric partner DP in vivo (Woo et al., 1997; Zhu et al., 1995a) . The exact role of these higher order complexes remains to be elucidated. It has recently been demonstrated that the spacer region utilized in these associations with cyclin/ Cdk complexes is structurally related to the interaction domain used by the inhibitory proteins from the CIP/ KIP family in their interaction with cyclin/Cdk2 complexes. In line with these ®ndings, p107 and p21 have been found to interact with Cdk2 complexes in a mutually exclusive manner (Zhu et al., 1995b) .
IFNs elicit a number of physiological responses in cells, the common denominator being the inhibition of viral replication (De Mayer and De Mayer, 1988) . Another well-established eect is their antiproliferative action, and IFNs are known to eectively inhibit growth of various untransformed and transformed cells (Taylor and Rozengurt, 1985) . This eect of IFNs has also been postulated to mediate, at least in part, their antitumor eects observed in some malignancies (Brenning et al., 1985; Kimchi et al., 1988) . A number of proteins previously identi®ed as key regulators of the cell cycle, such as c-myc, pRb, cyclic A, Cdk2, E2F, have been demonstrated as downstream targets in the growth-suppressive activity of IFNs (Kimchi, 1992; GrandeÂ r et al., 1997) . It has also been shown that cyclinD3 and cdc25A are rapidly downregulated in Daudi cells following IFN treatment (Tiefenbrun et al., 1996) . However, to date, no comprehensive model of the molecular mechanism mediating IFN's cell growthinhibitory action has emerged. We have previously shown that Cdk-inhibitors from both the INK4 and CIP/KIP family can be added to the growing list of target proteins that are regulated by IFN-a (Sangfelt et al., 1997b) , since IFN-a induced G1 arrest was found to be associated with the induction of p21 and p15.
The current study was undertaken to further explore the mechanism(s) by which IFN-a mediates G1 arrest, through a detailed analysis of both the early and late eects of IFN-a on cell cycle-regulatory proteins.
Results

Eects of IFN-a on cell cycle progression in Daudi and U-266 cells
We have previously shown that Daudi Burkitt's lymphoma and U-266 myeloma cells arrest in the G1 phase of the cell cycle following treatment with IFN-a (Sangfelt et al., 1997b) . In the previous study, this arrest was, however, not further characterized with respect to the exact point of blockage in G1. In order to characterize the G1 arrest induced by IFN-a in these (Table 1) . The decreased number of U-266 cells with G1 DNA content in cells treated with IFN-a for 72 h, compared with 48 h, is due to distortions in the DNA histograms of these cultures at this timepoint, as U-266 cells undergo apoptosis at longer exposure times to IFN-a (Sangfelt et al., 1997a) . The cellular protein content of cells cultured in the absence or presence of IFN-a was measured as an indirect parameter for determining whether IFN-a causes a blockage of cells in early or late G1 phase. Daudi cells but not U-266 cells, display a marked drop in protein content following 48 h of incubation with IFN-a ( Figure 1a and b, middle panels). Furthermore, there was a signi®cant decrease in mean cell size of IFN-a treated Daudi cells, whereas this was not the case for U-266 cells (data not shown). Since low protein content and decreased cell size are parameters indicative of G0 arrest, these results suggest that Daudi cells accumulate in a G0-like state following IFN-a treatment, in contrast to the arrest observed in U-266 cells. We next performed double staining of BrdU-pulse-labeled cells to determine whether the observed G1 arrest in U-266 cells is associated with a speci®c arrest point in the G1 phase. As can be seen in Figure 1a and b (upper panels), both Daudi and U-266 cells accumulated with a DNA content that was consistent with the G1 (2N) phase after 48 h of treatment. In Daudi cells, there was a clear distinction between the cells that did not incorporate the BrdU precursor and the few cells that were engaged in DNA synthesis (Figure 1a , lower panels). By contrast, in U-266 cells there was, in addition to an increased number of BrdU-negative cells of speci®c G1 DNA content, a newly recognizable cell population in early S phase with high BrdU staining intensity (Figure 1b , lower panels). These results indicate that a major group of IFN-a treated U-266 cells arrest in late G1/early S phase. The dierence between the G0 and G1 phases of the cell cycle has previously been established by the fact that certain growth-regulated genes, such as c-myc, are not expressed in G0 cells (Kaczmarek, 1986) . IFN-a treatment of Daudi cells results in decreased c-myc mRNA expression, ®rst detected around 4 ± 8 h, whereas expression of the c-myc homolog, L-myc, does not change during IFN-a treatment of U-266 cells (Sangfelt et al., 1997a , and data not shown). Another proliferation-associated protein used to dierentiate between quiescent cells and cells actively participating in the cell cycle is the nuclear protein Ki-67. Ki-67 protein is expressed in all phases of the cell cycle in proliferating cells, but is absent in quiescent, G0-arrested cells (Gerdes et al., 1984) . As shown in Table  1 Eects of IFN-a on expression levels and phosphorylation status of the pRb, p107 and p130 pocket proteins Given the importance of pocket proteins in the regulation of the G1/S transition, we next sought to investigate the eects of IFN-a treatment on the abundance and phosphorylation status, of pRb, p130 and p107, by immunoblot analysis.
In Daudi cells, the hyperphosphorylated form of pRb present in untreated, proliferating cells, was shifted to its hypophosphorylated, faster migrating form 8 ± 16 h after addition of IFN-a (Figure 2a) . At longer incubation times (48 ± 72 h), the levels of pRb protein was signi®cantly reduced (Figure 2a) . As previously described, no Rb protein was detected in U-266 cells (Sangfelt 1997b) , which is probably due to a genomic deletion within the RB gene in this cell line (Corradini et al., 1994) .
In Daudi cells, the migration pattern of p130 was signi®cantly changed following IFN-a treatment from mainly hyperphosphorylated forms to a hypophosphorylated form, as shown in Figure 2a (from predominantly form 3 to predominantly form 1 (Mayol et al., 1996) ). In contrast to Daudi cells, the shift was less pronounced in U-266, and there was no appearance of the most hypophosphorylated form (form 1) (Figure 2b ). Furthermore, we observed a diminished expression of p130 following IFN-a treatment in U-266 cells (Figure 2b ).
The phosphorylation pattern of the third pocket protein, p107, was more dicult to examine in Daudi cells, since they express multiple species of this protein, the bands of which overlap during SDS ± PAGE (Figure 2a) . Furthermore, IFN-a treatment results in a reduction of all p107 forms at around 24 h in these cells (Figure 2a) .
The slowly migrating forms of p107 were undetectable in the U-266 cell line, and only a single p107 species was visible in these cells. This form was slightly shifted towards a more hypophosphorylated, faster migrating form of p107 (Figure 2b ). In addition, there was a slight increase in total p107 levels at longer incubation times (Figure 2b , lanes 10 and 12).
These results show that IFN-a aects phosphorylation and expression of all three pocket proteins, and demonstrate for the ®rst time that IFN-a treatment leads to a dephosphorylation, not only of pRB, but also of the other pocket proteins p130 and p107.
Eects of IFN-a treatment on G1 Cdk activity
Since G1 Cdks have been shown to be essential regulators of pocket protein phosphorylation, as well as being rate-limiting for progression into S phase, we next sought to examine if IFN-a causes a downregulation in G1 Cdk activity. Cells were treated for the indicated times with IFN-a, whereafter G1 kinase complexes were immunoprecipitated and their kinase activities analysed. First, IFN-a caused a signi®cant loss of Cdk2-associated kinase activity in both Daudi and U-266 cells ( Figure 3a ). The decrease in Cdk2 kinase activity was detectable within 8 h of IFN-a addition, and maximal inhibition was observed at around 48 h in both cell lines (Figure 3a) . The kinase activity of Cdk4 could not be accurately measured, because the available Cdk4 antibodies (from three dierent sources) do not immunoprecipitate detectable levels of speci®c Cdk4 kinase activity in these cell lines. Similar diculties have also been noted by others (Hannon and Beach, 1994; ReynisdottõÁ r et al., 1995) . Instead, Cdk4-associated kinase activity was indirectly analysed using antibodies speci®c for cyclin D3, which is the only cyclin D member detectably expressed in these cell lines (Pokrovskaja et al., 1996 ; and data not shown). As shown in Figure 3b , cyclin D3-associated kinase activity was rapidly lost in both cell lines following IFN-a treatment. Previous work has shown that cells lacking functional Rb protein express low levels of cyclin D-associated kinase activity (Parry et al., 1995) . In agreement with this, the relative basal levels of cyclin D3-associated kinase activity was approximately four times higher in Daudi cells, compared to U-266 cells. Interestingly, the loss of cyclin D3-associated kinase activity occurred faster in U-266 cells, compared to Daudi cells, reaching maximal inhibition after 8 h of incubation ( Figure  3b ). One reason for this may be that in U-266 cells, in contrast to Daudi cells, IFN-a rapidly upregulates the expression of two CKIs, p15 and p21 (see below), both capable of binding and inhibiting Cdk4 complexes. Furthermore, the relatively low levels of cyclin D3/ Cdk4 complexes in U-266 cells may be more rapidly saturated by CKIs. These results show that IFN-a treatment is able to eciently inhibit the activity of all the G1 Cdks that are predominantly associated with hyperphosphorylation of pocket proteins and subsequent G1 progression and S phase transition.
IFN-a induced accumulation of CKIs in Daudi and U-266 cells
Inhibition of G1 Cdk activity by extracellular signals has, in several systems, been shown to be due to changes in CKI levels. We therefore investigated whether the IFN-a induced G1 arrest in the cell lines under study correlated with changes in the levels of Ink4 or Cip/Kip inhibitors. As we have described previously, IFN-a treatment leads to a rapid increase in the level of p21 in both Daudi and U-266 cells ( Figure  4a and b) (Sangfelt et al., 1997b) . The p21 protein levels reach a peak at around 8 ± 16 h of IFN-a treatment, whereafter the levels start to decline (Figure 4) . Interestingly, at 72 h of incubation, p21 protein was found to decrease below baseline levels in Daudi cells (Figure 4a ; compare lanes 1 and 7). Furthermore, IFN-a causes an increase in p15 protein levels with kinetics similar to p21 in U-266 cells, whereas no p15 expression could be detected in Daudi cells (Sangfelt et al., 1997b) . Recent studies indicating Cyclin D3-complexes immunoprecipitated with anti-cyclin D3 antibodies (C-16), were assayed for phosphorylation of GST-Rb substrate. 100% activity corresponds to Cdk2-and cyclin D3-associated kinase activity from untreated control cells (0 h). As a control for the speci®city of kinase activity of Cdk2-and cyclin D3-precipitated complexes, an irrelevant antibody was used in parallel immunoprecipitations (neg.) cooperativity between p15 and p27, as well as p21 and p27 (ReynisdottõÁ r and MassagueÂ , 1997), prompted our interest in examining whether p27 is also a target for regulation by IFN-a. As can be seen in Figure 4a and b, there was signi®cant accumulation of p27 protein in both cell lines following IFN-a treatment. Elevation of p27 protein was most prominent in Daudi cells, being ®rst detected after 8 ± 16 h of IFN-a treatment, and then increasing approximately 20-fold above untreated cells at 72 h (Figure 4a ). In U-266 cells, p27 accumulation was ®rst detected between 16 and 24 h, reaching a plateau at 48 h, with an approximate ®vefold increase in total p27 expression levels ( Figure  4b ). The variability of the fold induction was not due to a dierence in total p27 expression levels after IFNa treatment, but rather to variable baseline levels between these cell lines (Figure 4a and b, lane 1) . Furthermore, the increase in total levels of p27 protein in both cell lines was re¯ected as an increase in p27 levels at the single cell level as detected by immunohistochemistry, which also revealed a translocation of p27 from a predominantly cytoplasmic localization in untreated cells, to a predominantly nuclear localization in cells treated with IFN-a for 48 ± 72 h (data not shown), which is in accordance with data obtained studying the location of p27 in TGF-b arrested cells (ReynisdottõÁ r and MassagueÂ , 1997) .
The observed dierence in basal steady-state protein levels between Daudi and U-266 cells correlated with the steady-state levels of the p27 transcript in these cell lines (data not shown). p27 mRNA levels did not change signi®cantly following IFN-a treatment in either cell line (data not shown), indicating that the accumulation observed at the protein level is regulated post-transcriptionally.
These results indicate that not only p21 and p15, but also p27 are targets for regulation by IFN-a in these two growth-arrested cell lines. The p21 and p15 upregulation occurs well before the increase in p27 levels, suggesting that p27 participates in the secondary events involved in regulating cell cycle arrest following IFN-a treatment.
Eects of IFN-a treatment on the composition of G1 Cdk complexes
We ®rst examined whether IFN-a treatment causes changes in the composition of Cdk4 complexes. As shown in Figure 5a , there was a rapid increase in the amount of p21 bound to Cdk4 in Daudi cells. At longer incubation times (48 h), the amount of Cdk4-bound p21 decreased to baseline levels, and at 72 h there was less p21 complexed with Cdk4 than in untreated cells (Figure 5a; compare lanes 1 and 7) . The amount of Cdk4-bound p27 following IFN-a treatment paralleled the total expression level of p27 in this cell line. Increased binding of p27 was ®rst detected from around 8 h, and then gradually increased to high levels at 72 h (Figure 5b, lanes 1 through 7) . Moreover, the high level of Cdk4-bound p27 at 48 ± 72 h coincided with the release of Cdk4-bound p21 at these later timepoints. Repeated experiments showed that this shift in inhibitor binding occurs at about 48 h of treatment with IFN-a. The levels of Cdk4-bound cyclin D3 were not signi®cantly changed until 72 h, when there was a slight decrease in Cdk4-bound cyclin D3 (Figure 5c ). Interestingly, there was a gradual decrease in the total expression of cyclin D3 detectable already at 24 ± 48 h of IFN-a treatment (Figure 5d ). The reason for this apparent discrepancy between total and Cdk4-bound cyclin D3 levels is probably due to stabilization of cyclin D3 in Cdk complexes containing CKIs (Clurman et al., 1996; LaBaer et al., 1997) . Since there is no detectable p15 expression in Daudi cells (Sangfelt et al., 1997b) , Cdk4 complexes were not analysed for p15 binding in this cell line.
In U-266 cells, p21 binding to Cdk4 was similarly increased from around 4 ± 8 h of IFN-a addition, and thereafter decreased to baseline levels after 48 ± 72 h of Figure 4 Accumulation of p21 and p27 proteins following IFN-a treatment of Daudi (a) and U-266 (b) cells. Exponentially growing cell cultures were treated with IFN-a, total cell lysates were prepared from cells at the indicated times after IFN-a addition, subjected to SDS ± PAGE, and immunoblotted with speci®c antibodies against p21 (70) and p27 (57) (Figure 6a, lanes 1 through 7) . IFN-a treatment of U-266 cells also rapidly leads to increased expression and binding of p15 to Cdk4 (Figure 6b ) (Sangfelt et al., 1997b) , and similarly to p21, Cdk4-bound p15 was also found to decline at longer incubation times. Furthermore, as shown in Figure  6c , the gain in Cdk4-bound p21 and p15 was paralleled by reduced binding of p27 to Cdk4 at these early time points (Figure 6c, lanes 2 through 4) . However, at longer incubation times, the amount of Cdk4-bound p27 was signi®cantly elevated (Figure 6c ; compare lanes 1 and 6). As p15 and p27 binding to Cdk4 appears to be mutually exclusive (ReynisdottõÁ r and MassagueÂ , 1997), and since we were unable to detect p27-cyclin D3/Cdk4-p21 complexes (through immunoprecipitation of p27 followed by immunoblotting of these complexes with antibodies to p21 (data not shown)), the increased binding of both p15 and p21 to Cdk4, may be one explanation to the apparent loss of Cdk4-bound p27 in U-266 cells (see Figure 6a , b, and c, lanes 1 through 4). Furthermore, similar to Daudi cells, U-266 cells also display a shift in Cdk4-bound CKIs from p21 (and p15) to p27 at around 24 ± 48 h of IFN-a treatment (see Figure 6a , b and c). As discussed above, U-266 cells lack functional Rb protein, and concomitantly express low amounts of cyclin D3. Surprisingly, IFN-a treatment of U-266 cells leads to a 2 ± 3-fold accumulation of total levels of cyclin D3, as well as of Cdk4-bound cyclin D3 (Figure 6d and e), which is in contrast to IFN-a treated Daudi cells. This increase in cyclin D3 protein was evident already after 4 h of IFN-a addition, and reached an elevated plateau at 24 h of incubation.
Because INK4 proteins can interact with free Cdk4 but not with free D-type cyclins, and the levels of p15 bound to Cdk4 were proportional to the total levels of p15 in U-266 cells, we performed cyclin D3 immunoprecipitations in order to examine whether the increase in Cdk4-bound p15 in U-266 cells will inevitably lead to the dissociation of cyclin D/Cdk4 complexes. The fact that p15 coprecipitates with cyclin D3 (data not shown) probably re¯ects the fact that, in this system, p15 may bind to cyclin D3/Cdk4-complexes without causing dissociation of the cyclin and the Cdk, as has also been shown by others (ReynisdottõÁ r and MassagueÂ , 1997).
Finally, it should be noted that total Cdk4 protein levels did not change during the period of incubation with IFN-a in either Daudi or U-266 cells (Figures 5e  and 6f) , and reprobing the blots with anti-Cdk4 antibodies con®rmed that approximately equal amounts of Cdk4 complexes were immunoprecipitated and loaded on the gel for each time point (data not shown).
We then examined the composition of Cdk2 complexes following IFN-a treatment of these cell lines. As in the case of Cdk4, there was a rapid but transient increase in the amount of Cdk2-bound p21 in Daudi cells treated with IFN-a ( Figure 7a , lanes 1 through 7). Cdk2-bound p27 was hardly detectable in untreated Daudi cells, but reached high levels by around 48 h of incubation (Figure 7b , lanes 5 through 7). Also, in the Cdk2 complexes, the increased binding of p27 coincided with the decline of p21. When total cell extracts from Daudi cells were examined for cyclinE expression, three major forms (&53, &50 and &45 kD) were detected. When examining Cdk2-bound cyclin E, the 53 kD and 50 kD species could not be easily detected because of background from the immunoglobulin heavy chain of the Cdk2 antibody Figure 6 Eects on Cdk4-bound CKIs and cyclins in IFN-a treated U-266 cells. Exponentially growing U-266 cells were treated with IFN-a for the indicated times, and total cell lysates prepared. Cdk4 complexes were immunoprecipitated, and the amount of Cdk4-bound p21 (a), Cdk4-bound p15 (b), Cdk4-bound p27 (c), and Cdk4-bound cyclin D3 (d) was determined by immunoblotting of these precipitates with the antibodies described in Figure 5 . A p15 antibody (C-20) was used for analysis of Cdk4-bound p15. Total cyclin D3 (e) and total Cdk4 (f) were analysed by direct immunoblotting of total cell lysates. Data shown are representative of ®ve independent experiments used for immunoprecipitation. However, the &45 kD form was readily detectable and migrated as a doublet in untreated Daudi cells (Figure 7c , lane 1). Both Cdk2-bound cyclin E and total cyclin E levels, accumulated with increased incubation time ( Figure  7c and d, lanes 1 through 7). Furthermore, there was a clear shift towards the faster migrating form of the &45 kD doublet following IFN-a treatment ( Figure  7c, lanes 1 through 7) . We could also detect Cdk2-bound cyclin D3, but the levels of these complexes were low, and there were no changes in the amount of cyclin D3 which was bound to Cdk2 following IFN-a treatment of these cells (data not shown). In U-266 cells, the kinetics of binding of p21 and p27 to Cdk2 were almost indistinguishable from those of IFN-a treated Daudi cells; a rapid increase in the amount of Cdk2-bound p21 until 24 h of incubation was followed by an increase in Cdk2-bound p27 at the expense of Cdk2-bound p21 (Figure 8a and b, lanes 1  through 7) . Similar to the observation in Daudi cells, Cdk2-bound cyclin E, as well as total cyclin E, were also found to accumulate with increased incubation time (Figure 8c and d, lanes 1 through 7) . Interestingly, Cdk2-bound cyclin E migrated as a triplet in U-266 cells, and as for the situation in Daudi cells, was shifted towards the faster migrating form with increased incubation time (Figure 8c , lanes 1 through 7).
Cdk2 expression was examined during 72 h of incubation with IFN-a. As can be seen in Figures 7e and 8e, there was a loss of the faster migrating, activated form of Cdk2 (phosphorylated by CAK) (Gu et al., 1992) . In Daudi cells, there was virtually no activated Cdk2 after 72 h of IFN-a treatment, whereas in U-266 cells the reduction remained partial (Figure 7e and Figure 8e , lane 7). The loss of the faster migrating form of Cdk2 in response to IFN-a treatment lagged several hours behind the loss of Cdk2-associated kinase activity, and is thus probably not the primary event leading to Cdk2 inhibition, but rather a consequence of the increased binding of Cdk-inhibitors, as has been suggested by others .
In addition, total expression levels of cyclin A were examined following IFN-a treatment of Daudi and U-266 cells. In agreement with previous studies (Tiefenbrun et al., 1996) , the levels of cyclin A decreased gradually after long exposure to IFN-a in Daudi cells (24 h, data not shown). In contrast, cyclin A levels were unaected throughout the incubation period in U-266 cells (data not shown).
Eects of IFN-a treatment on cdc25A levels
Other mechanisms involved in the inhibition of Cdk activity could also be subject to regulation by IFN-a. It has for example been shown that Cdk activity can also be regulated by dephosphorylation on conserved tyrosine and threonine residues by the phosphatase cdc25A (Morgan, 1995) . Since this activating enzyme has recently been shown to be downregulated by IFN-a (Tiefenbrun et al., 1996) , we analysed total expression levels of cdc25A following IFN-a treatment in our system. As can be seen in Figure 9a , cdc25A expression decreased from 16 h of incubation with IFN-a in Daudi cells. In contrast, cdc25A expression was not changed throughout the period of incubation in U-266 cells (Figure 9b ).
Taken as a whole, the ®rst detectable change in G1 regulating complexes in IFN-a treated Daudi and U-266 cells is the upregulation of CKIs. These data thus suggest that the rapid induction of p21 (and p15 in U-266), and their increased binding to both Cdk4 and Cdk2, are involved in a primary response which inhibits these G1 kinases in the presence of IFN-a. Subsequent accumulation of p27, and the downregulation of cdc25A and cyclin D3 (in Daudi cells), implicate the importance of a second wave of eects in IFN-a induced G0 arrest.
Rearrangement of p107 and p130 complexes following the induction of CIP/KIP inhibitors by IFN-a
During cell cycle progression, both p130 and p107 have been found in multiprotein complexes that contain not only E2F, but also cyclin/Cdk2 kinases. Recently, it has been shown that CKIs from the CIP/KIP family, and the pocket proteins p130 and p107, share a Figure 8 Eects on Cdk2-bound CKIs and cyclins in IFN-a treated U-266 cells. Exponentially growing U-266 cells were treated with IFN-a for the indicated times and total cell lysates prepared. Cdk2 complexes were immunoprecipitated, and the amount of Cdk2-bound p21 (a), Cdk2-bound p27 (b), and Cdk2-bound cyclin E (c) was determined by immunoblotting of these precipitates with the antibodies described in Figure 7 . (c) Only the faster-migrating form of cyclin E could be detected due to the non-speci®c Ig heavy chain (IgH) signal, marked with an arrow. conserved, newly de®ned cyclin-binding motif. These properties form the basis for the mutually exclusive binding of p27 and p107/p130, respectively, to cyclin/ Cdk2 complexes (Shiyanov et al., 1996; Zhu et al., 1995b) . In the context of the eects of IFN-a on the expression and binding of p21/p27 to Cdk2 described above, we therefore tested whether this was associated with a decreased binding of p107/p130 to cyclin E/ Cdk2 complexes. Immunoprecipitations with anti-p107, anti-p130 or anti-Cdk2 antibodies, were performed on total extracts from untreated and IFN-a treated cells. Both cyclin E/Cdk2-p107 and cyclin E/Cdk2-p130 complexes were readily detectable in both Daudi and U-266 cells (Figure 10a and b) . There was a signi®cant reduction in the amount of p107-bound Cdk2 in both Daudi and U-266 cells treated with IFN-a for 48 h (Figure 10a, lanes 1, 2, 4 and 5) . In Daudi cells, the dierence in the amount of p107-bound Cdk2 was less obvious, probably due to a reduction in total p107 levels at this time point (Figures 2a and 10a) . Similarly, the amount of cyclin E bound in complex with p107 was also found to decrease following IFN-a treatment in both of these cell lines (data not shown). A similar shift in complex composition was found when p130-bound components were examined. As shown in Figure  10b , p130-bound Cdk2 was reduced in Daudi and U-266 cells after treatment with IFN-a for 48 h. Interestingly, only the faster migrating, active form of Cdk2 was found in complex with either p107 or p130, in the presence or absence of IFN-a (Figure 10a and  b) . Moreover, we also found similar changes in complex composition when Cdk2 immunoprecipitates were examined for the binding of p130, since Cdk2-bound p130 was found to decrease signi®cantly in IFN-a treated Daudi and U-266 cells at the corresponding time points (data not shown).
Therefore, under physiological conditions within the cell, IFN-a induced accumulation of Cdk2-bound CIP/ KIP inhibitors, and the subsequent inhibition of Cdk2 activity, is not only re¯ected by the phosphorylation level of p130 and p107, but also in the nature of the cyclin E/Cdk2-p130/p107 complex composition.
H9 cells resistant to growth arrest by IFN-a are unable to upregulate CKIs and activate pocket proteins
We have previously shown that IFN-a is unable to induce cell cycle arrest in the T-cell lymphoma line H9 (Sangfelt et al., 1997a, b) . This resistance to IFN-a mediated growth inhibition is not due to a defective signal transduction pathway, since IFN-a causes a 40-fold induction of the IFN-a stimulated gene, 2',5' oligoadenylate synthetase, indicating an intact IFN-a signaling pathway in this cell line. Moreover, although highly induced at the mRNA level following IFN-a incubation, p21 protein is lacking in this cell line (Sangfelt et al., 1997b) . As can be seen in Figure 11 , Figure 11 Immunoblot analysis of p27, p130 and p107 expression following IFN-a treatment of H9 cells. Exponentially growing cell cultures were treated with IFN-a, total cell lysates were prepared from cells at the indicated times after IFN-a addition, subjected to SDS ± PAGE, and immunoblotted with p27 (57), p130 (cat. no. #R27020), and p107 (C-18) antibodies. The asterisk beside the p130 panel indicates the position of a nonspeci®c band cross-reacting with the monoclonal p130 antibody. Representative data from several independent experiments are shown IFN-a induced cell cycle arrest O Sangfelt et al p27 expression levels were not changed following IFNa incubation. Interestingly, p27 migrates as a doublet in H9 cells, in contrast to Daudi and U-266 cells, in which p27 protein is present as a single form. Furthermore, we have previously shown that H9 cells possess a homozygous deletion of the p15/p16 genes (Borgonovo Brandter et al., 1996) . In agreement with the lack of induction of CKIs, IFN-a had no eect on the phosphorylation or expression of either p130 or p107 in H9 cells ( Figure 11 ). As previously demonstrated, pRb expression could not be detected in this cell line (Sangfelt et al., 1997b) . Finally, it should be mentioned that H9 cells are sensitive to IFN-a induced apoptosis (Sangfelt et al., 1997a) , and our experiments were therefore terminated at 48 h of treatment, the time at which many cells display signs of apoptosis. Together, these data show that there are no IFN-a induced changes in the protein expression of these CKIs in H9 cells, further implicating the importance of these inhibitors in IFN-a induced inhibition of G1 Cdk activity and growth arrest.
Discussion
IFNs have long been known to have cell growth inhibitory capacities. This antiproliferative action has been proposed to be of major importance in the antitumor response, but may also be important in antiviral action against viruses which require cellular proliferation for replication. The exact mechanism behind the ability of IFNs to arrest cell growth is, however, not known. To analyse the molecular mechanism(s) that mediate the inhibition of cell proliferation by IFN-a, we found it important to de®ne the type of arrest. A detailed analysis of the characteristics of the growth-arrested cell populations, shows that the type of arrest that occurs diers signi®cantly between Daudi and U-266 cells. The reduced protein content, cell size and Ki-67 expression after IFN-a treatment of Daudi cells shows that these cells accumulate in a quiescent, G0-like state. These changes were not observed in growth-arrested U-266 cells that rather arrest at the G1/S phase transition.
The IFN-a induced G0-like state in Daudi cells is also re¯ected by changes observed in several components of the basic cell cycle machinery. Reminiscent of normal quiescent cells such as T-lymphocytes and ®broblasts (Nourse et al., 1994; Hengst and Reed, 1996) , IFN-a treated Daudi cells: (1) accumulate high p27 levels; (2) lose the active, CAK-phosphorylated form of Cdk2, and (3) exhibit the pocket proteins p130 and pRb in their active hypophosphorylated form (Mayol et al., 1996) . Furthermore, G0-arrested Daudi cells exhibit almost undetectable c-myc and cdc25A levels, and the levels of the cyclins D and A, as well as of pRb and p107, are also signi®cantly reduced.
Several notable dierences were found in late G1-arrested U-266 cells. Firstly, there was a lack of pRb expression in U266 cells and only partial dephosphorylation of p130, whilst p107 was shifted to a more hypophosphorylated form, without any downregulation in its total abundance. Secondly, myc, cdc25A and cyclin A levels were not downregulated in IFN-a arrested U-266 cells. Interestingly, and in contrast to Daudi cells, there was a 2 ± 3-fold increase in cyclin D3 protein levels in G1 arrested U-266 cells. The reason for this increase may be due to cell cycle synchronization in the late G1 phase or increased stability of cyclin D3 protein (Nicolescu et al., 1998) . These various dierences are all plausible explanations for the dierent point of arrest between Daudi and U-266 cells.
To reveal the mechanism behind these changes, we investigated whether they were preceded by IFN-a induced modulations in G1 Cdk complex activity and composition. Cdk4 and Cdk2 coimmunoprecipitation experiments showed that the primary events involved in the inhibition of G1 Cdk activity, were not associated with decreases in cyclin or Cdk levels. Rather, the rapid induction and increased binding of the CKIs, p21 and p15 (in U-266 cells) to these G1 Cdks is suggested to cause the primary inhibition of kinase activity. The increased binding of p21 and p15 was, however, transient, but when the levels of these CKIs decreased there was a concomitant accumulation of the CKI p27 in both Cdk4 and Cdk2 complexes.
What is the mechanism behind the upregulation of CKIs in these cells? Both p15 and p21 seem to increase mainly as a result of transcriptional regulation, since their mRNA levels rise rapidly following IFN-a treatment (Sangfelt et al., 1997b) . The IFN-a induced increase in p27 protein levels, on the other hand, does not seem to result from transcriptional regulation, as there was no signi®cant increase in p27 mRNA levels following IFN-a treatment of these cells, similar to results reported in other systems . The main determinants of p27 protein stability seems to be translational ecacy as well as the cellular activity of Cdk2, as active Cdk2 phosphorylates p27 and targets it for proteosomal degradation (Hengst et al., 1996; Vlach et al., 1997) . It is thus possible that the marked rise in p27 levels observed following IFN-a treatment is due to the coinciding inhibition of Cdk2 activity. Probably, a similar mechanism also explains the observed increase in cyclin E protein levels, as this cyclin has been shown to be regulated in a similar manner (Clurman et al., 1996) .
A loss of the faster migrating, active threonine 160-phosphorylated form of Cdk2 (Gu et al., 1992) , was Figure 12 Proposed model of the molecular background of IFNa induced G0/G1 arrest observed following longer incubation times with IFN-a possibly through CKI induced prevention of CAK mediated phosphorylation of newly formed Cdks (Aprelikova et al., 1995) . This eect, however, lagged several hours behind the increase in p21 expression, and the loss in Cdk2-associated kinase activity. In U266 cells, a small fraction of CAK phosphorylated Cdk2 was still observed after 48 ± 72 h of IFN-a treatment, correlating with some remaining Cdk2-associated kinase activity, and the reduction in the eciency of G1 arrest in these cells. A similar incomplete inactivation of Cdk2 by CIP/KIP inhibitors has also been demonstrated in other pRb-negative cells (Nicolescu et al., 1998) . Even so, the reduced activity of Cdk2 observed in U-266 cells following IFN-a treatment is sucient to prevent the majority of these cells from entering S phase.
Importantly, the current study also demonstrates that IFN-a not only decreases pRb phosphorylation, but also signi®cantly alters the phosphorylation level of the other pocket proteins p130 and p107 (see Figure 2a and b).
There are some important dierences between our data and those of other studies of the eects of IFN-a on cell cycle regulating proteins. In the most extensive previous study (Tiefenbrun et al., 1996) , the eects of IFN-a on CKI expression levels were not evaluated, and, in some contrast to our data, a more rapid reduction in cyclin D3 and cdc25A levels was observed. These eects were suggested to be responsible for priming cell cycle arrest through the inhibition of Cdk4 and Cdk2 activities (Tiefenbrun et al., 1996) . Our data rather suggest that the rapid induction of p21, and possibly p15 (in U-266 cells) is of major importance, and our results provide the following evidence to support a possible role for CKIs in IFN-a-mediated inhibition of G1 Cdk activity: (i) p21 induction (and p15 in U-266 cells) is the ®rst change to be observed, occurring well before the reduction in cdc25A and cyclin D3 levels; (ii) increased p21 expression is paralleled by an increased binding of p21 to both Cdk2 and Cdk4 kinases, coinciding with the decrease of G1 Cdk activity. These events occur at a timepoint where there is no noticeable cell cycle arrest; (iii) induction of p21 occurs in both growth arrested cell lines. In contrast, decreased expression of cdc25A and cyclin D3 occurs only in Daudi cells, and therefore does not seem to be mandatory for IFN-a induced G1 arrest. A number of other observations implicate the importance of CKIs in IFN-a induced G0/G1 arrest; (iv) we have observed the rapid induction of p21 in other cell lines of both lymphoid and non-lymphoid origin following treatment with IFN-a. Induction of p15 following IFN-a treatment seems to be more cell type restricted (Sangfelt et al., unpublished data) and (v) the third cell line employed in this study, H9, was completely resistant to the cell growth-inhibitory eects of IFN-a. In this cell line, no p21 protein could be observed either before or following exposure to IFN-a, although p21 mRNA levels were highly induced following IFN-a treatment (Sangfelt et al., 1997b) . Whether this is the reason for resistance to IFN's antiproliferative action in this cell line remains to be shown. The reason for the discrepancy between this study and that by Tiefenbrun et al. (1996) could be that dierent clones of Daudi cells were used or to the fact that the latter study did not focus on the CKI's.
The concept that a single cytokine activates more than one pathway, each may be necessary but not sucient by itself to cause G1 arrest, makes it dicult to establish the exact molecular mechanism behind IFN-a induced G1 arrest. The pathway(s) involving the Myc oncoproteins is one example. In our system, c-myc expression is lost in Daudi cells at early time points (at around 4 ± 8 h of treatment, data not shown). In U-266 cells, which do not express c-myc, but exhibit signi®cant amounts of L-myc, IFN-a was unable to downregulate L-myc mRNA levels (data not shown). Thus, similar to the eects of IFN-a on cdc25A, downregulation of myc is not mandatory for IFN-a induced cell growth arrest, since U-266 cells arrest without an apparent reduction of myc expression levels.
It has previously been demonstrated that forced over-expression of CIP/KIP inhibitors leads to a loss of the association between cyclin E/A/Cdk2-p107/p130 complexes through the competition for binding to cyclins E and A (Zhu et al., 1995b) . In the present study, we demonstrate that the increase in p27 levels observed after treatment with IFN-a was accompanied by a similar eect. The importance of multi-component complexes between cyclin E/A/Cdk2 and p107/p130/ E2F is not yet fully understood, and the eect of disrupting these complexes by p27 is similarly unclear, but may involve changes in E2F-driven transcription (Dimri et al., 1996) , or may aect the compartmentalization of active Cdk2 complexes. An interesting observation was that only the active, CAK-phosphorylated form of Cdk2, takes part in complex formation with p130/p107 in these cell lines (see Figure 10) .
The eects of IFN-a on the cell cycle machinery shows similarities with the alterations observed during TGF-b induced G1 arrest, including the cooperation of the three CKIs p15, p21 and p27 (ReynisdottõÁ r et al., 1995) . IFN-a treatment, contrary to that of TGF-b, results in a strong increase in p27 protein levels subsequent to the increased expression of p21 and p15. In U266 cells, in which p15 is induced, we observed an initial reduction in Cdk4-bound p27, in analogy with the eects of TGF-b. At longer incubation times, when Cdk4-bound p15 and p21 decline, large quantities of p27 also become bound to Cdk4, probably because of the strong increase in steady state levels of p27.
IFN-a has been previously shown to have diverse eects on cell cycle regulating proteins (GrandeÂ r et al., 1997) . In the present study, we have performed a detailed and extensive analysis of the changes observed in G1 regulating proteins and the temporal relationship of these changes to IFN-a induced growth arrest. Based on our ®ndings, we have constructed a putative model for the molecular changes responsible for IFN-a induced cell cycle arrest (Figure 12 ). The present results, however, raise important questions for future investigations.
Materials and methods
Cell lines and culture conditions
Three malignant lymphoid cell lines were used in this study; the myeloma cell line U-266, the Burkitt lymphoma cell line Daudi and the H9 cell line, derived from the continuous T-cell lymphoma line Hut-78 (Sangfelt et al., 1997b) . All cell lines were grown as previously described (Sangfelt et al., 1997b) . To assure exponential growth, Daudi and H9 cell cultures were set up 16 h before addition of IFN-a (5000 U/ ml), whereas U-266 cell cultures were set up 24 h prior to addition of IFN-a. For experiments in which cells were grown in the presence and absence of IFN-a for up to 72 h, new medium with or without IFN-a was added once after harvesting of the 24 h time point. Cells were harvested at dierent times after addition of IFN-a and washed twice with PBS prior to preparation for further experiments.
Antibodies and IFN preparation
Recombinant human IFN-a 2 b (from Schering-Plough, Kenilworth, NJ, USA) was used in all experiments. The following antibodies were utilized in this study. Monoclonal Ki-67 antibody (MIB-1) was purchased from Immunotech (Marseille, France). Antibodies to pRb (G3-245), Cdk2 (cat. no. 15536E), Cdk4 (cat. no. 14946E and 15156E), Cdk6 (cat. no. 13446E), cyclin E (HE12), cyclin A (BF683), p21 (6B6), p27 (G173-524), p16 (G175-405) were from PharMingen (San Diego, CA, USA) and antibodies to pRb (769), p107 (C-18), p130 (C-20), cyclin D3 (C-16), p27 (C-19), Cdk4 (H-22), p15 (C-20) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal antibodies to Cdk2 (55), p27 (57), p21 (70) and p130 (cat. no. #R27020) were purchased from Transduction Laboratories (Lexington, KY, USA). An additional rabbit polyclonal antibody against Cdk4 used in these experiments was from Clontech Laboratories (cat. no. #3516-1). Cdk6 polyclonal antisera was a generous gift from G Hannon and D Beach (CSH Labs., NY, USA). p107 (a mixture of SD 6, SD 9 and SD 15) and Cdc25A (polyclonal antisera) were generous gifts from E Harlow (MGHCC, Boston, MA, USA) and I Homan (GCRC, Heidelberg, Germany), respectively.
Flow cytometric analysis
DNA histograms, ®xation of cells, DNA labeling and measurements of cellular protein content was performed and analysed as previously described (Sangfelt et al., 1997a; Heiden et al., 1990) . The ACAS (Ahrens Flow System, Bargteheide/Hamburg, Germany) program was used for the contour plot analysis. For BrdU labeling, cells were cultured with or without IFN-a for 48 h, pulse-labeled for 2 h with 15 mM BrdU, washed and ®xed in 4% formaldehyde for 15 min followed by 95% ethanol. Cyto¯uorimetric analysis of BrdU and DAPI was performed as previously described (Sangfelt et al., 1997a) . Cell size was determined by measuring forward scatter intensities with a FACScan (Becton-Dickinson), and analysed using LysisII software.
Immunohistochemistry analysis
Ki-67 expression in individual cells was analysed in cytospin preparations from cells harvested at dierent times of incubation with IFN-a. Frozen cell preparations were ®xed in ice-cold acetone for 2 min, washed in phosphate-buered saline (PBS), and incubated with Ki-67 diluted 1:25 in PBS containing 1% bovine serum albumin (Sigma Chemical Co.). Immunostaining was performed using labeled streptavidin biotin (LSAB) kit (DAKO LSAB+kit, Peroxidase, Universal K0679), according to the instructions of the manufacturer (DAKO, CA, USA). More than 300 cells were evaluated in several independent experiments.
Western blot analysis
Preparation of cell extracts, electrophoresis, Western blotting and hybridization was performed as previously described (Sangfelt et al., 1997b) . As a control for equal loading and transfer, membranes were stained with Ponceau red (Sigma). In addition, as an internal control, blots were reprobed with Cdk4 antibodies, as Cdk4 expression was found to be unaected by IFN-a treatment in the cell lines under study.
Immunoprecipitations
For immunoprecipitation, cells were washed twice in PBS and frozen in liquid nitrogen, Whole protein extracts were prepared as previously described (Sangfelt et al., 1997b) . Lysates were pre-cleared with protein A-Sepharose beads (Pharmacia Biotech AB, Uppsala, Sweden) with gentle agitation for at least 2 h at 48C. Lysates representing 1 mg of whole protein extracts were incubated with polyclonal antibodies to Cdk4, Cdk2, p27 and cyclin D3 for 2 ± 4 h at 48C. Antibody-associated complexes were then bound to prewashed protein A-Sepharose beads, washed and denatured as described (Sangfelt et al., 1997b) . Precipitated proteins were resolved by separation on 12% SDS ± PAGE gels, electroblotted and incubated with the antibodies described in ®gure legends. For immunoprecipitations with p107 and p130 antibodies, 1.5 ± 2 mg of whole protein extract was used. Antibody-associated complexes were absorbed onto protein A-Sepharose beads (for the polyclonal antibodies) or protein G plus/protein A agarose (for the monoclonal antibodies) (Calbiochem, La Jolla, CA, USA). Precipitated proteins were resolved by separation on 10% SDS ± PAGE gels, electroblotted and incubated with the antibodies described in Figure  10 . Due to cross-reactivity of the p130 polyclonal antibody (C-20) with p107, a sequential p130 immunoprecipitation was performed on the supernatant from p107 precipitated complexes (p107 immuno-depleted protein lysate). In addition, p130 immunoprecipitations were performed with monoclonal p130 antibodies (cat. no. #R27020).
Kinase assays
Lysis buer and immunoprecipitation were as described above. Cdk2-associated kinase activity was analysed as previously described (Sangfelt et al., 1997b) . For measurement of cyclin D3-associated kinase activity, 200 mg of whole protein extract that had been precleared twice with protein ASepharose was used. The kinase assay was performed essentially as described (Matsushime et al., 1994) . Brie¯y, anti-cyclin D3 precipitated immunocomplexes were washed ®ve times in lysis buer and once in 50 mM HEPES (pH 7.5) containing 1 mM DTT. Washed complexes were suspended in 30 ml of kinase buer (50 mM HEPES, pH 7.5, 10 mM MgCl 2 , 1 mM DTT, 2.5 mM EGTA, 10 mM b-glycerophosphate, 0.3 mM sodium orthovanadate, 1 mM NaF, 20 mM ATP) and the kinase reaction was started by adding 10 mCi [g- 
Northern blot analysis
Total cellular RNA isolation and Northern blot analysis were performed as described (Sangfelt et al., 1997b) . Northern blot ®lters (Hybond C-extra, Amersham) were hybridized with cmyc and L-myc cDNA probes (kindly provided by Dr L Asker, Karolinska Institute, Stockholm, Sweden), and with a gel-puri®ed 600 bp NheI/XhoI restriction fragment for the p27 cDNA (a kind gift from Dr J MassagueÂ , Memorial Sloan-Kettering Cancer Center, NY, USA). The amount of RNA in each sample was normalized by hybridizing the ®lters with a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe. All probes were labeled as previously described (Sangfelt et al., 1997b) . Hybridization signals from Northern, Western and kinase assay ®lms were quantitated as described (Sangfelt et al., 1997b) .
